Author Affiliation: Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, DC.
Controversies Section Editor: Phil B. Fontanarosa,
MD, Executive Deputy Editor.
Just as it leads in biomedical innovation, the pharmaceutical industry
is proud to play a leading role in sponsoring continuing medical education
(CME) for physicians—an effort that serves the overriding mutual interest
to ensure that patients receive the most up-to-date and appropriate care.
The accelerating pace of biomedical progress, in such fields as biochemistry,
molecular biology, cell biology, immunology, genetics, and information technology,
makes it more imperative than ever for physicians to stay abreast of the latest
medical innovations and treatments. Particularly at a time when patients are
increasingly demanding and receiving more health care information, the pharmaceutical
industry and the medical profession are obligated to do all they can to ensure
that physicians, the key prescribers of prescription medicines in the health
care system, are thoroughly informed about the latest medical developments.
Holmer AF. Industry Strongly Supports Continuing Medical Education. JAMA. 2001;285(15):2012-2014. doi:10.1001/jama.285.15.2012